{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T14:14:32Z","timestamp":1789913672001,"version":"4.0.1"},"reference-count":25,"publisher":"Frontiers Media SA","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2014.00189","type":"journal-article","created":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T07:00:42Z","timestamp":1398927642000},"source":"Crossref","is-referenced-by-count":16,"title":["Cross-Protective Immunity to Leishmania amazonensis is Mediated by CD4+ and CD8+ Epitopes of Leishmania donovani Nucleoside Hydrolase Terminal Domains"],"prefix":"10.3389","volume":"5","author":[{"given":"Dirlei","family":"Nico","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele Crespo","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus Vin\u00c3\u00adcius","family":"Alves-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisangela Oliveira","family":"Freitas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Morrot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Bahia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos","family":"Palatnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauricio M.","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarisa B.","family":"Palatnik-de-Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2014,5,1]]},"reference":[{"issue":"2","key":"B1","doi-asserted-by":"publisher","first-page":"177","DOI":"10.4103\/0974-777X.62881","article-title":"Leishmaniasis vaccine: where are we today?","volume":"2","author":"Kedzierski","year":"2010","journal-title":"J Glob Infect Dis"},{"issue":"5","key":"B2","doi-asserted-by":"publisher","first-page":"e35671","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar","year":"2012","journal-title":"PLoS One"},{"issue":"Suppl S","key":"B3","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1017\/S0031182006001831","article-title":"Leishmania vaccines: progress and problems","volume":"133","author":"Kedzierski","year":"2006","journal-title":"Parasitology"},{"key":"B4","first-page":"1","article-title":"Evolution, classification and geographic distribution","volume-title":"The Leishmaniases in Biology and Medicine. Biology and Epidemiology","author":"Lainson","year":"1987","edition":"1st ed"},{"issue":"15","key":"B5","doi-asserted-by":"publisher","first-page":"3116","DOI":"10.1111\/j.1365-294X.2011.05162.x","article-title":"Reproductive strategies and population structure in Leishmania: substantial amount of sex in Leishmania Viannia guyanensis","volume":"20","author":"Rougeron","year":"2011","journal-title":"Mol Ecol"},{"issue":"2","key":"B6","doi-asserted-by":"crossref","first-page":"125","DOI":"10.4269\/ajtmh.1996.55.125","article-title":"The logic of visceral leishmaniasis control","volume":"55","author":"Dye","year":"1996","journal-title":"Am J Trop Med Hyg"},{"issue":"14","key":"B7","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1016\/j.vaccine.2008.01.023","article-title":"Vaccines for leishmaniasis in the fore coming 25 years","volume":"26","author":"Palatnik-de-Sousa","year":"2008","journal-title":"Vaccine"},{"issue":"2","key":"B8","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.vaccine.2011.11.005","article-title":"The development and clinical evaluation of second-generation leishmaniasis vaccines","volume":"30","author":"Duthie","year":"2012","journal-title":"Vaccine"},{"issue":"4","key":"B9","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1093\/ije\/15.4.572","article-title":"Controlled field trials of a vaccine against new world cutaneous leishmaniasis","volume":"15","author":"Antunes","year":"1986","journal-title":"Int J Epidemiol"},{"issue":"8","key":"B10","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.trstmh.2005.04.002","article-title":"Failure of a killed Leishmania amazonensis vaccine against American cutaneous leishmaniasis in Colombia","volume":"99","author":"V\u00c3\u00a9lez","year":"2005","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"45","key":"B11","doi-asserted-by":"publisher","first-page":"5245","DOI":"10.1016\/j.vaccine.2005.07.001","article-title":"Failure of a multi-subunit recombinant leishmanial vaccine (MML) to protect dogs from Leishmania infantum infection and to prevent disease progression in infected animals","volume":"23","author":"Gradoni","year":"2005","journal-title":"Vaccine"},{"issue":"19","key":"B12","doi-asserted-by":"publisher","first-page":"3333","DOI":"10.1016\/j.vaccine.2010.02.089","article-title":"Treatment of canine visceral leishmaniasis by the vaccine Leish-111f + MPL-SE","volume":"28","author":"Trigo","year":"2010","journal-title":"Vaccine"},{"issue":"9\u00e2\u20ac\u201c10","key":"B13","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/S0264-410X(00)00339-X","article-title":"A phase III trial of Efficacy of the FML-vaccine against canine kala-azar in an endemic area of Brazil (S\u00c3\u00a3o Gon\u00c3\u00a7alo do Amarante, RN)","volume":"19","author":"da Silva","year":"2000","journal-title":"Vaccine"},{"issue":"39","key":"B14","doi-asserted-by":"publisher","first-page":"4991","DOI":"10.1016\/j.vaccine.2008.07.029","article-title":"Immunogenicity assay of the Leishmune\u00c2\u00ae vaccine against canine visceral leishmaniasis in Brazil","volume":"26","author":"Borja-Cabrera","year":"2008","journal-title":"Vaccine"},{"issue":"6","key":"B15","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1586\/14760584.7.6.833","article-title":"The FML-vaccine against canine visceral leishmaniasis: from the second generation to the synthetic vaccine","volume":"7","author":"Palatnik-de-Sousa","year":"2008","journal-title":"Expert Rev Vaccines"},{"issue":"13","key":"B16","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1016\/j.vaccine.2005.11.061","article-title":"The FML-vaccine (Leishmune\u00c2\u00ae) against canine visceral leishmaniasis: a transmission blocking vaccine","volume":"24","author":"Saraiva","year":"2006","journal-title":"Vaccine"},{"issue":"27","key":"B17","doi-asserted-by":"publisher","first-page":"3505","DOI":"10.1016\/j.vaccine.2009.03.045","article-title":"Decrease of the incidence of human and canine visceral leishmaniasis after dog vaccination with Leishmune\u00c2\u00ae in Brazilian endemic areas","volume":"27","author":"Palatnik-de-Sousa","year":"2009","journal-title":"Vaccine"},{"issue":"2","key":"B18","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1590\/S0037-86821996000200008","article-title":"The FML (fucose mannose ligand) of Leishmania donovani. A new tool in diagnosis, prognosis, transfusional control and vaccination against human kala-azar","volume":"29","author":"Palatnik-de-Sousa","year":"1996","journal-title":"Rev Soc Bras Med Trop"},{"issue":"1","key":"B19","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/0001-706X(93)90006-W","article-title":"Leishmania donovani surface glycoproteins GP36, is the major immunogen component of the fucose mannose ligand (FML)","volume":"53","author":"Palatnik-de-Sousa","year":"1993","journal-title":"Acta Trop"},{"issue":"15","key":"B20","doi-asserted-by":"publisher","first-page":"4418","DOI":"10.1021\/bi702448s","article-title":"Structural basis for substrate specificity in group I nucleoside hydrolases","volume":"47","author":"Iovane","year":"2008","journal-title":"Biochemistry"},{"issue":"6","key":"B21","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.bbapap.2009.02.011","article-title":"Crystal structures of T. vivax nucleoside hydrolase in complex with new potent and specific inhibitors","volume":"1794","author":"Vers\u00c3\u00a9es","year":"2009","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"B22","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S0166-6851(02)00010-5","article-title":"Nucleoside hydrolase from Leishmania (L.) donovani is an antigen diagnostic for visceral leishmaniasis","volume":"120","author":"Santana","year":"2002","journal-title":"Mol Biochem Parasitol"},{"issue":"7","key":"B23","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.ijpara.2006.03.006","article-title":"Towards multilocus sequence typing of the Leishmania donovani complex: resolving genotypes and haplotypes for five polymorphic metabolic enzymes (ASAT, GPI, NH1, NH2, PGD)","volume":"36","author":"Mauricio","year":"2006","journal-title":"Int J Parasitol"},{"issue":"22","key":"B24","doi-asserted-by":"publisher","first-page":"9375","DOI":"10.1073\/pnas.0703678104","article-title":"Evolutionary and geographical history of the Leishmania donovani complex with a revision of current taxonomy","volume":"104","author":"Lukes","year":"2007","journal-title":"Proc Nat Acad Sci U S A"},{"issue":"30","key":"B25","doi-asserted-by":"publisher","first-page":"21114","DOI":"10.1074\/jbc.274.30.21114","article-title":"Nucleoside hydrolase from Leishmania major. Cloning, expression, catalytic properties, transition state inhibitors, and the 2.5-\u00c3\u00a5 crystal structure","volume":"274","author":"Shi","year":"1999","journal-title":"J Biol Chem"}],"container-title":["Frontiers in Immunology"],"original-title":[],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T21:35:48Z","timestamp":1565386548000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2014.00189\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,1]]},"references-count":25,"URL":"https:\/\/doi.org\/10.3389\/fimmu.2014.00189","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,1]]}}}